If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Humalog®
- Full Prescribing Information
Humalog® U-100 (insulin lispro injection)
100 units/mL - Full Prescribing Information
Humalog® U-200 (insulin lispro injection)
200 units/mL - Full Prescribing Information
Humalog® MIX50/50™ (50% insulin lispro protamine suspension 50% insulin lispro injection [rDNA origin])
100 units/mL - Full Prescribing Information
Humalog® MIX75/25™ (75% insulin lispro protamine suspension 25% insulin lispro injection [rDNA origin])
100 units/mL
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
HUMALOG® (insulin lispro) 200 Units/mL: Do Not Use in a Pump
HUMALOG® (insulin lispro) 200 units/mL is not indicated for approved use in a continuous subcutaneous insulin infusion pump.
Do NOT administer IL-200 using an insulin pump, CSII.1
Administering IL-200 via CSII is not recommended because
this may result in overdose and severe hypoglycemia (low blood glucose)
IL-200 is only available in a Pen, and
Enclosed Prescribing Information
HUMALOG® (insulin lispro injection [rDNA origin]), Lilly
1. Humalog [package insert]. Indianapolis, IN: Eli Lilly and Company; 2019.
Glossary
CSII = continuous subcutaneous insulin infusion
IL-200 = Humalog® (insulin lispro injection) 200 units/mL
Pen = KwikPen®
Date of Last Review: December 06, 2019
Contact Lilly
Call Us
If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.
Available Mon - Fri, 9am - 7pm EST
